NO. 80
Time:
Friday, September. 5 2025, 4:00 p.m.
Location:
Multi-Function Hall, 2nd Floor, North Basic Research Building
Host:
Chuan-Yuan Li (李川源)
Chinese Institutes for Medical Research, Beijing
Speaker:
Don W. Cleveland
Distinguished Professor and Chair
Department of Cellular and Molecular Medicine
University of California, San Diego
TITLE:
TDP-43 in Neurodegeneration: phase separation, aggregation, and therapy
ABSTRACT:
In 2050, the proportion of the world's population over 60 years old will nearly double. One of the most impactful consequences of aging is the decline of cognitive functions and associated neurodegenerative diseases. TDP-43, an essential nuclear RNA binding protein, is found to mis-localize to cytoplasm and form inclusions in almost every age-dependent neurodegenerative disease, including > 90% of instances of amyotrophic lateral sclerosis, > 40% of frontal temporal dementia and Alzheimer’s disease patients. My lab has long investigated the disease mechanisms of TDP-43 proteinopathy. Our work has revealed TDP-43's essential functions in splicing and regulatory pathways that underlie the pathology's formation.
SELECTED PAPERS
1. Melamed Z, López-Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, Freyermuth F, McMahon MA, Beccari MS, Artates JW, Ohkubo T, Rodriguez M, Lin N, Wu D, Bennett CF, Rigo F, Da Cruz S, Ravits J, Lagier-Tourenne C, Cleveland DW. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat Neurosci. 2019 Feb; 22(2): 180-190.
3. Lu S, Hu J, Arogundade OA, Goginashvili A, Vazquez-Sanchez S, Diedrich JK, Gu J, Blum J, Oung S, Ye Q, Yu H, Ravits J, Liu C, Yates JR 3rd, Cleveland DW. Heat-shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liquid-to-gel transition. Nat Cell Biol. 2022 Sep; 24(9): 1378-1393.